
Omicron COVID variant: All you need to know about…
The UK Health Security Agency (UKHSA) has confirmed a total of 246 Omicron cases in the UK, as of Sunday 5 December 2021. This includes cases in people who have not travelled internationally recently, suggesting the Omicron variant has started to spread among the community. The UKHSA believe that the cases are down to a number of separate, unconnected introductions of the new variant into England.
“Increased case detection through focused contact tracing has led to more cases of the Omicron variant being identified and confirmed, as we have seen in other countries globally,” said Dr Jenny Harries, the chief executive of the UKHSA.
“We are continuing to monitor the data closely. Teams nationally and locally are working at pace to identify and trace all close contacts of every Omicron case. It is critical that anyone with COVID-19 symptoms isolates and gets a PCR test immediately.”
As there is evidence of community transmission, the UKHSA is urging everyone to follow the new government COVID-19 guidance to wear face coverings in shops and when on public transport.
Read more coronavirus news:
In response to the new Omicron variant, the rollout of the COVID vaccination booster programme is being expanded in the UK and the minimum gap between the second vaccine dose and booster has been reduced from six to three months.
“Christmas is around the corner and it’s absolutely crucial that everybody who is eligible gets their booster jab to top-up their immunity before spending time with loved ones,” said Health and Social Care Secretary Sajid Javid.
“While our brilliant scientists learn more about the new Omicron variant, we need to do everything we can to strengthen our defences and vaccines are the best way to do that. This is a national mission and we all have a role to play – so roll up your sleeves and get protected as soon as you can.”
Anyone over 40 who had their second dose of a coronavirus vaccine at least three months ago is able to book in for their booster jab. Under 40s are expected to be invited for their booster by the NHS in the coming weeks.
Omicron has now been detected on all six continents, with 608 Omicron cases worldwide according to data from the GISAID COVID tracking initiative.
The whole of the UK is now imposing new travel restrictions to attempt to stop the spread of the Omicron strain. All international arrivals will need to take a PCR test within two days of arriving in the UK and must self-isolate until they have received a negative test result.
Will face masks protect against the new strain?
“We have been through all of this before with the Alpha and Delta variant,” said Dr Julian Tang, a clinical virologist at the University of Leicester. “But the main difference is that the scientific evidence for the effectiveness of masks and social distancing has increased – and there is more conviction now amongst scientists that these measures do work to reduce the spread of the virus.”
Tang warns that while masking, social distancing and improved ventilation reduces the risk, they do not offer 100 per cent protection.
“Wearing any mask or face covering (cloth, surgical, etc.) is better than none; some degree of social distancing is better than none; some ventilation is better than none.
“A combination of these is also better than just one, e.g. if you can open the windows (even just a little) on a bus, and sit spaced out in every other seat, and wear a mask, this will protect you more than any of these measures individually.”

Since 19 July 2021, when England dropped the last of its legal coronavirus restrictions on public behaviours, COVID vaccines have kept a balance between hospitality staying open and the number of new cases and hospital admissions.
“So the crucial question with the new Omicron variant in this context is: will this new variant change this balance? We don’t have enough data to assess this now – so some caution and reimposition of some restrictions is not a bad idea, whilst we accumulate more data to make such an assessment.”
How many cases of the Omicron variant have been detected in the UK?
On 5 December the UKHSA revealed there had been a total of 43,992 new COVID-19 cases, of which 86 were due to the Omicron strain. Since its discovery, there have been 246 confirmed cases of Omicron in the UK.
The new COVID-19 strain was first identified in South Africa from samples taken from 14 to 16 November 2021. It is still unknown when and where the new variant first emerged.
As of 6 December 2021, according to data from the GISAID COVID tracking initiative, there have been 608 Omicron cases confirmed globally. Of these, 228 have been identified in South Africa, 33 in Ghana and 27 in the United States. The new variant has been identified in a total of 37 countries.
What are the symptoms of the Omicron variant?
It is too early to say for sure if the Omicron strain has different symptoms. However, a doctor in South Africa who treated Omicron patients says they are experiencing fatigue, body aches and mild headaches.
“Most of them are seeing very, very mild symptoms and none of them so far have admitted patients to surgeries,” Dr Angelique Coetzee told Reuters. “We have been able to treat these patients conservatively at home… The most predominant clinical complaint is severe fatigue for one or two days.”
As with all other coronavirus strains, the Omicron variant can cause severe disease or death, particularly for those who are clinically vulnerable.
The main symptoms of COVID-19, according to the NHS, are:
- a high temperature – this means you feel hot to touch on your chest or back (you do not need to measure your temperature)
- a new, continuous cough – this means coughing a lot for more than an hour, or three or more coughing episodes in 24 hours (if you usually have a cough, it may be worse than usual)
- a loss or change to your sense of smell or taste – this means you’ve noticed you cannot smell or taste anything, or things smell or taste different to normal
The NHS say that most people who have symptoms of COVID-19 will have at least one of the above.
According to a statement issued by the World Health Organization (WHO) on 28 November, there is preliminary research suggesting increased instances of hospitalisation with COVID-19 in South Africa.
“But this may be due to increasing overall numbers of people becoming infected, rather than a result of specific infection with Omicron,” write the WHO. “There is currently no information to suggest that symptoms associated with Omicron are different from those from other variants. Initial reported infections were among university students – younger individuals who tend to have more mild disease – but understanding the level of severity of the Omicron variant will take days to several weeks.”
Will vaccines still work against the Omicron variant?
There is not yet enough evidence to say conclusively whether the B.1.1.529 variant will be able to evade protection from coronavirus vaccines. However, representatives from Pfizer, Moderna and Oxford/Astrazeneca have all responded to the new variant.
Reuters report that AstraZeneca are “looking into B.1.1.529 to understand more about it and the impact on the vaccine,” and are conducting research in Botswana and Eswatini to understand how the vaccine works against this new virus variant.
Pfizer and BioNTech have been studying emerging strains and say they are developing updated versions of the Pfizer-BioNTech COVID-19 vaccine to potentially address specific variants.
Meanwhile, a statement from Moderna says they will rapidly advance an Omicron-specific booster candidate.

At the briefing with South African Minister of Health Dr Joe Phaahla, experts revealed what is known about the new strain.
Mutations to the coronavirus spike protein affect the ability of the virus to enter human cells. Of the 30 mutations found in the B.1.1.529 spike protein, several changes have been identified that are associated with resistance to antibodies from either a COVID-19 vaccine or natural immunity following prior infection.
The Omicron variant also has a deletion to a gene that is similar to one found in Alpha, Beta, Gamma and Lambda, which is thought to strengthen the virus’s ability to evade immune system responses.
Is the Omicron variant more transmissible?
The UK Health Secretary Sajid Javid made a statement to the House of Commons on 25 November in which he expressed concern over the spread of B.1.1.529.
“We are concerned that this new variant may pose a substantial risk to public health,” said Javid. “Early indications show this variant may be more transmissible than the Delta variant, and current vaccines may be less effective against it.”
According to Javid, the UK Health Security Agency is worried “about the rise in cases in Southern Africa [because] these populations should have significant natural immunity [from prior infections].” However, Javid said we cannot yet be sure that the exponential growth of COVID-19 cases in South Africa is due to B.1.1.529 but that it’s likely there are more cases of the Omicron variant than currently sequenced.
Professor Tulio de Oliveira, a virologist and Director of the Centre for Epidemic Response and Innovation in South Africa, spoke at a briefing on COVID-19 developments that was arranged by the South Africa department of health.
“[The B.1.1.529 variant has a] very unusual constellation of mutations,” said de Oliveira at the briefing. He explained that there are around 50 mutations in the B.1.1.529 genome, 30 of which are in the spike protein. To compare, the Delta variant has 13 mutations.
Of these 30 mutations, some have been well characterised by scientists and have a known impact on transmissibility and the virus’s ability to evade immunity. The new strain is known to have mutations near an area on the spike protein associated with more efficient cell entry, which means enhanced transmissibility among populations. It also has mutations that are known to increase the infectivity, fitness, and virulence of SARS-CoV-2.
However, de Oliveira said many of the mutations have been rarely seen before, and so are not fully understood.
How are we tracking the spread of Omicron?
The WHO’s variant under monitoring designation means the WHO will be monitoring and tracking the global spread of B.1.1.529, and will be undertaking its own assessment of the variant’s characteristics and public health risk.
It also means countries that are members of WHO – which the UK is – are required to:
- Work to enhance efforts towards a more representative picture of circulating variants, including making data publicly available
- Perform field investigations to improve understanding of the characteristics of B.1.1.529
- Conduct laboratory investigations to better understand the new variant
- Monitor the spread of B.1.1.529 and its interaction with other circulating variants to asses its potential for outcompeting
What other variants have been identified in the UK?
As of 26 November 2021, there are five strains considered to be ‘of concern’ by PHE, including the Delta and Alpha variants.
The PHE are monitoring a total of 16 variants.
About our expert, Dr Julian Tang
Dr Tang is an honorary associate professor and clinical virologist at the University of Leicester. Since 2014 he has led a team researching viral infections, particularly respiratory viruses, like influenza and SARS-CoV-2.